Innospec Inc. (NASDAQ:IOSP) Shares Acquired by Ingalls & Snyder LLC

Ingalls & Snyder LLC increased its holdings in shares of Innospec Inc. (NASDAQ:IOSP) by 1.0% in the third quarter, Holdings Channel reports. The firm owned 28,868 shares of the specialty chemicals company’s stock after acquiring an additional 272 shares during the period. Ingalls & Snyder LLC’s holdings in Innospec were worth $3,265,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in IOSP. Price T Rowe Associates Inc. MD boosted its position in shares of Innospec by 5.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,228 shares of the specialty chemicals company’s stock worth $2,222,000 after buying an additional 916 shares during the period. DekaBank Deutsche Girozentrale purchased a new position in Innospec in the 1st quarter worth approximately $66,000. CWM LLC grew its position in Innospec by 239.6% in the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after acquiring an additional 448 shares in the last quarter. Linden Thomas Advisory Services LLC raised its stake in shares of Innospec by 2.0% during the second quarter. Linden Thomas Advisory Services LLC now owns 12,042 shares of the specialty chemicals company’s stock valued at $1,488,000 after purchasing an additional 235 shares during the period. Finally, SG Americas Securities LLC lifted its position in shares of Innospec by 660.1% during the second quarter. SG Americas Securities LLC now owns 9,767 shares of the specialty chemicals company’s stock worth $1,207,000 after purchasing an additional 8,482 shares in the last quarter. 96.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 8th.

Innospec Stock Down 0.4 %

Shares of Innospec stock traded down $0.52 during trading hours on Tuesday, hitting $119.88. 3,954 shares of the company’s stock traded hands, compared to its average volume of 108,915. Innospec Inc. has a twelve month low of $103.97 and a twelve month high of $133.71. The company has a market cap of $2.99 billion, a PE ratio of 21.01 and a beta of 1.09. The stock has a 50 day simple moving average of $114.68 and a 200-day simple moving average of $118.15.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings data on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.35. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The firm had revenue of $443.40 million during the quarter, compared to analyst estimates of $442.13 million. During the same quarter last year, the firm earned $1.59 EPS. Innospec’s quarterly revenue was down 4.5% on a year-over-year basis. As a group, equities research analysts predict that Innospec Inc. will post 5.88 EPS for the current year.

Innospec Increases Dividend

The business also recently disclosed a Semi-Annual dividend, which was paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th were paid a dividend of $0.79 per share. This represents a yield of 1.3%. This is an increase from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend was Monday, November 18th. Innospec’s dividend payout ratio is 27.57%.

Insiders Place Their Bets

In other news, Director Milton C. Blackmore sold 1,035 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total value of $127,222.20. Following the completion of the sale, the director now directly owns 9,028 shares in the company, valued at approximately $1,109,721.76. The trade was a 10.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.35% of the stock is owned by company insiders.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.